exam 4 Flashcards

(96 cards)

1
Q

ultra fast and short acting insulins

A

lispro

aspart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ultra long acting insulins

A

glargine (lantus-bedtime dose)

determir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

slows gastric emptying and appetite modulator

A

amylin-pramlintide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

incretin analog
decrease blood glucose
inhibits glucagon secretion
take with sulfonylurea/metformin

A

exenetide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

best for obese type 2
dec liver gluconeogenesis
dec insulin resistance
doesn’t induce hypoglycermia

A

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

sulfonylureas
increase insulin secretion
affects atp sensitive k channels

which one is used for gestational diabetes?

A

glipizide and glyburide

glyburide is good for gestational

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

thiazolidinediones
-anti hyperglycemic
increase insulin sensitivity without inc release

A

pioglitazone

rossiglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

alpha-glucosidase inhibitor
-for mild to moderate fasting hyperglycemia
slows carb digestion and absorption which blunts blood glucose

A

acarbose

miglitol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ddp-iv inhibitors
prevent breakdown of incretin
inc insulin

A

sitagliptin

saxagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

opposite of sulfonylurea, opens atp sensitive k+
inhibits insulin release
also a antidiuretic

A

diazoxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

for severe hypoglycemia

inc liver glucose output

A

glucagon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

for GH deficiency, sematopause, mitogenic-anti-apoptotic

subQ at night

A

somatotropin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

long term tx for skeletal muscle, organ growth
mitogenic and anti apoptotic effects
subq with meal

A

mecasermin IGF-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

inhibit GH secretion
for acromegaly, carcinoid and pancreatic tumors
dec cAMP and Ca2+

A

octreotide-somatostatin, SRIF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

gh analog of HGH

**normalizes IGF-1 and best drug for acromegaly

A

Pegvisomat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ergot da agonist for GH/PRL

normalizes IGF-1

A

bromocriptine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

stimulated by inc ecf osmolality, dec bp, hemorrhage, RA2 system

treat diabetes insipidus (reduced water permability and polyuria)

A

Vasopressin-ADH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

which moa of vasopressin is this?

phospholipase c-> IP3 ca2+ ->contraction of vascular and gi smooth muscle

A

V1a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

which moa of vasopressin is this?

adenylate cyclase -> cAMP-> aquaporin insertion into luminal membrane of collecting ducts

A

V2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

synthetic analog of adh, longer duration, more potent v2

A

desmopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

uterine contraction

A

oxytocin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

synthetic acth
evaluate adrenal sufficiency
no therapeutic use

A

cosyntropin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

glucocorticoid receptor antagonist

adrenal hyperfunction, symptom control, assess acth secretion

A

mifepristone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

mineralocorticoid antagonist

for hypersecretion

A

spironiolactone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
glucocorticoid antagonist | -block cholesterol -> pregnolone
aminoglutethimide
26
glucocorticoid antagonist | block cortisol synthesis
metyrapone
27
glucocorticoid antagonist | inhibit p450 required for steroid synthesis
ketaconazole
28
active transport of iodide
iodide trapping
29
iodination of tyrosine residues of thyroglobulin
iodine organification
30
converts T4 to T3
-5' deiodinase
31
extreme iodide excess inhibits organification and hormone secretion
wolff-chaikoff effect
32
t4-prodrug
thyroxine
33
t3-potent active hormone
triiodothyronine
34
synthetic t4=drug of choice tx for myxedema coma-usually elderly with h/o hypothyroidism
levothyroxine
35
synthetitc t3 with rapid absorption
liothyronine
36
mixture of t4 and t3
liotrix
37
contraindications of T4 therapy?
adrenal insufficiency coumarin anticoags DM CV dz
38
anti-thyroidal agent with thiocarbamide group | inhibits thyroid peroxidase
thionamides =propylthiouracil methimazole
39
anti-thyroidal also partially inhibits t4->t3 faster acting -indicated for preggers
propylthiouracil
40
anti-thyroidal | longer duragion of action
methimazole
41
``` anti-thyroidal most common tx in US -for complete or partial destruction of thyroid with no injury to adjacent tissue -no preggers can use with BB, ca2+ channel antags ```
Radioactive iodine (131)I
42
raises serum ca2+ g protein-coupled receptor -induces osteoclast -increase reabsorption of ca2+ and mg2+
PTH
43
lowers serum ca2+
calcitonin
44
increases intestinal ca2+ absorption
vitamin d
45
abnormality of bone remodeling excessive bone turnover disruption of normal architecture deformities
pagets
46
defect of bone mineralization vitamin d deficiency or resistance rickets
osteomalacia
47
increases extracellular ca2+ increase new bone formation decrease fracture risk (osteoporosis) not used to treat hypocalcemia
teriparatide acetate (PTH analog)
48
use: pseudo/hypoparathyroidism, osteoporosis, rickets moa: intracellular nuclear hormone receptor superfamily -facilitates intestinal ca2+ absorption, increases calbindins expression, stimulates ca efflux into blood and synthesis of osteocalcin to produce bone matrix
calcitriol cholecalciferol
49
use: severe hypercalcemia, osteoporosis (when hrt is CI), pagets inactivates osteoclasts and increases renal excretion of ca2+ secreted by c cells of thyroid, stimulated by inc serum ca+
calcitonin
50
- bind to hydroxyapatite crystals, incorporated into bone matrix, taken up by osteoclasts - incapacitate osteoclasts and inhibits bone resorption - for osteoporosis in postmeno women, pagets, hypercalcemia ae: hypo, jaw osteonecrosis
bisphosphonates | -alendronate, ibandronic acid, zoledronic acid
51
- increase bone mineral density | - human anit-rank ligand monoclonal antibody that inhibits proliferation, differentiation, maturation of pre-osteoclasts
denosumab
52
tissues that express 5alpha-reductase->dihydrotestosterone (DHT)
type 1: skin, bone, liver | type 2: urogenital tissues, genital skin
53
tissues that express p450 aromatase ->estradiol (estrogen)
fat liver bone
54
- binds androgen receptor | - nuclear receptor
testosterone moa
55
-weak androgen, progestin, glucocorticoid activity -inhibits gonadal steroidogenesis -in females, inhibits midcycle gonadotropin surge for endometriosis, fibrocystic breast dz, hematological disorders
danazol
56
5alpha-reductase inhibitor -blocks production of dht use for benign prostatic hyperplasia
finasteride
57
used for pituitary suppression to inhibit gonadotropin release
estradiol
58
- antiandrogen with progestin activity | - use with estrogen to treat hirutism
cyproterone acetate
59
non-steroidal competitive antagonists -use for prostate cancer with GnRH agonist block action of adrenal androgens
flutamide
60
blocks both aldosterone and androgen receptors | inhibits 17alpha-hydroxylase
spironolactone | hirsutism
61
commonly abused anabolic steroid, to avoid detection on earlier drug tests
tetrahydrogesterone
62
what is IVRA
intarvenous regional anesthesia
63
where is IVRA used?
UE and LE surgery
64
advantage of IVRA
simple, reliable, rapid return to function, cost effective
65
Concerns of IVRA
duration of surgery, TQ time, LA toxicity
66
Locals used with IVRA
lidocaine, bupivacaine, ropivacaine, prilocaine
67
IVRA technique
``` IV contralateral limb butterfly in injured limb, in foot prepare la two TQ applied distal to fib head exsanguinate the limb inflate prox tq inject la through access if tq pain- inflast distal and release proximal ```
68
Adjuncts to IVRA
opiods, muscle relaxants, nsaids, clonidine, potassium, alkalizing agents
69
IVRA complications
``` seizures cardiac arrest/death incomplete anesthesia injection pain tq pain compartment syndrome neuro damage dysphoria, dizziness, facial tingling mistakenly deflating cuff injecting wrong drug ```
70
stimulate DA receptors
ABPR apomorphine bromocriptine-ERGOT pramipexole ropininole
71
``` anti-parkinsonion antiviral young anti cholinergic block uptake of DA while stim DA release ```
Amantidine
72
increases synthesis of DA
levodopa/carbidopa
73
inhibits da catabolism (MAO-B inhibitor) dont take with SSRI
selegiline
74
block breakdown of DA for pt with motor side effects from L-DOPA
Tolcapone-cns/peripheral | Entacapone-peripheral
75
neuroleptic for tourette's
haloperidol
76
alpha-2 agonists | first line tx for tourettes
clonidine
77
block da receptors | tourettes tx
fluoxetine
78
gaba-b receptor agonist | for als
baclofen
79
reduce glutamate release | for als
riluzole
80
I.A. - halogenated hydrocarbon - slow onset - recovery must be accompanied with opiod/no
halothane
81
I.A. - halogenated hydrocarbon - rapid onset/recovery - most widely used
isoflurane
82
I.A. - halogenated hydrocarbon - medium onset/recovery - deep anesthesia
enflurane
83
I.A. - halogenated hydrocarbon - rapid - good induction agent
sevoflurane
84
I.A. - analgesic - poor muscle relaxant - incomplete anesthesia - rapid, vasoconstrictor
nitrous oxide
85
- ultra short acting barbituate | - induce anesthesia prior to administration of another agent
thiopental
86
- benzodiazepine - slower than barbituates - anterograde amnesia - sedative
midazolam
87
-opioid analgesics
fentanyl | sufentanil
88
- gaba-rapid | - most common inducer
propofol
89
ultra short acting agent | -no analgesia, inducer
etomidate
90
dissociative anesthesia, catatonia, amnesia, unresponsiveness, ANALGESIC, no loss of conscousness blocks NMDA receptors
ketamine
91
Ester derived local anesthesias
procaine | chloroprocaine
92
amide derived locals
all the other caines
93
order of Locals from fast to slow onset
RLP, P, ME, BL, C | rop, lido, prilo
94
order of locals from short to longer duration
PCL, M,P,R,BL,E | pro, chloro, lido
95
1% solution =
1g/100ml or 10mg/ml
96
enhances the duration of L.A.'s
epinephrine